TipRanks
Aldeyra Therapeutics (DE:137)
FRANKFURT:137
Germany Market
137
Aldeyra Therapeutics
RESEARCH TOOLSreports

Aldeyra Therapeutics (137) Income Statement

0 Followers

Aldeyra Therapeutics Income Statement

Last quarter (Q2 2026), Aldeyra Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Aldeyra Therapeutics's net income was $-5.45M. See Aldeyra Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 35.27M$ 60.12M$ 42.79M$ 62.68M$ 56.22M
Depreciation and Amortization
$ 251.99K$ 249.62K$ 262.78K$ 258.71K$ 264.18K
EBITDA
$ -31.69M$ -53.68M$ -35.21M$ -60.07M$ -55.77M
Operating Income
$ -35.27M$ -60.12M$ -42.79M$ -62.68M$ -56.22M
Other Income/Expenses
$ 1.42M$ 4.27M$ 5.25M$ 655.35K$ -1.56M
Pretax Income
$ -33.85M$ -55.85M$ -37.54M$ -62.02M$ -57.78M
Net Income
$ -33.85M$ -55.85M$ -37.54M$ -62.02M$ -57.78M
Per Share Metrics
Basic EPS
$ -0.56$ -0.94$ -0.64$ -1.06$ -1.07
Diluted EPS
$ -0.56$ -0.94$ -0.64$ -1.06$ -1.07
Weighted Average Shares Outstanding
 60.06M 59.48M 58.94M 58.41M 54.04M
Weighted Average Shares Outstanding (Diluted)
 60.06M 59.48M 58.94M 58.41M 54.04M
Currency in USD

Aldeyra Therapeutics Earnings and Revenue History